The need for oncogenetic counselling: Ten years' experience of a regional Oncogenetic Clinic

Acta Oncologica

Volumn 43, Issue 7, 2004, Pages 637-649

  Henriksson, Karin ^a   Olsson, Hákan ^a   Kristoffersson, Ulf ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BREAST CARCINOMA; CANCER GENETICS; CANCER SCREENING; CANCER SUSCEPTIBILITY; COLORECTAL CARCINOMA; ENDOMETRIUM CARCINOMA; EXPERIENCE; FAMILY HISTORY; GENE MUTATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GERM LINE; HIGH RISK POPULATION; HUMAN; MEDICAL STAFF; MOLECULAR GENETICS; ONSET AGE; OVARY CARCINOMA; PATIENT REFERRAL; PEDIGREE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SWEDEN;

AMBULATORY CARE FACILITIES; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MELANOMA; MUTATION; NEOPLASMS; OVARIAN NEOPLASMS; PEDIGREE; SWEDEN;

EID: 9444265972     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860410018520     Document Type: Article

References (29)

1. Eeles R, Murday V. The cancer family clinic. In: Eeles R, Ponder B, Easton D, Horwich A. eds. Genetic predisposition to cancer. London: Chapman & Hall; 1996. p. 356-71.
2. The National Board of Health and Welfare. Cancer incidence in Sweden 2002 [available at: http://www.sos.se/FULLTEXT/42/2003-42-11/2003-42-11.pdf, 2003].
3. Stopfer JE. Genetic counseling and clinical cancer genetics services. Semin Surg Oncol 2000; 18(4): 347-57.
4. Lemon SJ, Tinley S, Fusaro RM, Lynch HT. Cancer risk assessment in a hereditary cancer prevention clinic and its first years experience. Cancer 1997; 80: 606-13.
5. Lynch HT, Watson P, Shaw TG, Lynch JF, Harty AE, Franklin BA, et al. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer, Part 1: Studies of cancer in families. Cancer 1999; 86(Suppl II): 2449-56.
6. Love RR, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985; 38(4): 289-93.
7. Douglas FS, O'Dair LC, Robinson M, Evans DG, Lynch SA. The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet 1999; 36(4): 309-12.
8. Kerr B, Foulkes WD, Cade D, Hadfield L, Hopwood P, Serruya C, et al. False family history of breast cancer in the family cancer clinic. Eur J Surg Oncol 1998; 24(4): 275-9.
9. Glanz K, Grove J, Le Marchand L, Gotay C. Underreporting of family history of colon cancer: correlates and implications. Cancer Epidemiol Biomarkers Prev 1999; 8(7): 635-9.
10. Brain K, Norman P, Gray J, Rogers C, Mansel R, Harper P. A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk. Br J Cancer 2002; 86(2): 233-8.
11. Lynch HT, Watson P, Tinley S, Snyder C, Durham C, Lynch J, et al. An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. Cancer Genet Cytogenet 1999; 109(2): 91-8.
12. Epstein SA, Lin TH, Audrain J, Stefanek M, Rimer B, Lerman C. Excessive breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. High-Risk Breast Cancer Consortium Psychosomatics 1997; 38(3): 253-61.
13. Claus EB, Risch N, Thompson WD. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat 1993; 28(2): 115-20.
14. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994; 73(3): 643-51.
15. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999; 116(6): 1453-6.
16. Hodgson S, Maher E. A practical guide to human cancer genetics. Cambridge: Cambridge University Press; 1999.
17. Hallowell N. A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. Psychooncology 2000; 9(6): 486-95.
18. Borgen PI, Hill AD, Tran KN, Van Zee KJ, Massie MJ, Payne D, et al. Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 1998; 5(7): 603-6.
19. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996; 2(2): 169-74.
20. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260(5109): 812-6.
21. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease, Neurology 1994; 44(8): 1533-6.
22. Håkansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes AM, et al. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 1997; 60(5): 1068-78.
23. Loman N. Clinical aspects of hereditary breast cancer. Thesis. Lund: Lund University, 2003.
24. Rostagno P, Gioanni J, Garino E, Vallino P, Namer M, Frenay M. A mutation analysis of the BRCA1 gene in 140 families from southeast France with a history of breast and/or ovarian cancer. J Hum Genet 2003; 48(7): 362-6.
25. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10.000 individuals. J Clin Oncol 2002; 20(6): 1480-90.
26. Arver B, Borg Å, Lindblom A. First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm. Genet Test 2001; 5(1): 1-8.
27. Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, et al. A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res 1997; 57(12): 2474-7.
28. Julian-Reynier C, Eisinger F, Chabal F, Aurran Y, Bignon YJ. Nogues C, et al. Cancer genetic clinics: why do women who already have cancer attend? Eur J Cancer 1998; 34(10): 1549-53.
29. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302(5645): 643-6.